浙江大学医学院博士研究生导师简介：谢幸

　　7.浙江省科技厅基金(ID J30119)，脐血干细胞库及其在卵巢癌中的应用;(2001.1-2003.12);主持。

　　8.浙江省自然科学基金 (ID 3999116), IL-7和IL-2联合转染卵巢癌细胞的体外研究;(2000.1-2002.12);主持。

　　9.浙江省自然科学基金(ID 397461),IL-2受体基因在抗卵巢癌中的作用;(1999.1-2001.12);主持。

　　代表论文：已在国内外各种学术期刊发表论著300余篇，其中SCI收录期刊论文60余篇。

　　1.Shi YF, Xie X, Zhao CL, Ye DF, Lu SM, Hor JJ, Pao CC. Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours. Br J Cancer 1996;73(10):1216-1219.

　　2.Stevenson AFG, Xie X, Kunstmann P. Cell culture of biopised endometrial after danazol/hormonal therapy: a study of growth features and fertility effects. Indian J Exper Biolo 2000; 38:1192-1200.

　　3.Ye D, Xie X, Lu W, Chen H, Cheng B. Growth inhibition of interleukin-2 receptor gene-tranduced peripheral blood lymphocytes on human ovarian cancer cells. Chin Med J (English) 2001; 114(3): 303-307.

　　4.Dong MY, Xie X, Wang ZP, He J, Zhou JH, Cheng Q. Impaired mixed lymphocyte reaction in intrahepatic cholestasis of pregnancy. Gynecol Obstet Invest 2002; 54(4):191-195.

　　5.Xie X, Lu WG, Ye DF, Chen HZ, Fu YF. The value of curettage in diagnosis of endometrial hyperplasia. Gynecol Oncol 2002;84 (1):135-139.

　　6.Chen HZ, Ye DF, Xie X, Chen B, Lu WG. VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma. Gynecol Oncol 2004; 94(3):630-635.

　　7.Wang H, Xie X, Lu WG, Ye DF, Chen HZ, Li X, Cheng Q. Ovarian carcinoma cells inhibit T cell proliferation: suppression of IL-2 receptor beta and gamma expression and their JAK-STAT signaling pathway. Life Sci 2004; 74(14):1739-1749.

　　8.Xie X, Ye D, Chen H, Lu W, Cheng B, Zhong H. Interleukin-7 and suppression of local peritoneal immunity in ovarian carcinoma. Int J Gynaecol Obstet 2004; 85(2):151-158.

　　9.Xie X, Ye DF, Chen HZ Lu WG, Fu YF, Cheng B, Zhu H. Effect of interleukin-7 gene transaction into ovarian carcinoma cell line SKOV3 in vitro and in vivo. Gynecol Oncol 2004; 92(2):578-585.

　　10.Ye F, Chen HZ, Xie X, Ye DF, Lu WG, Ding ZM. Vascular endothelial growth factor (VEGF) and ovarian carcinoma cell supernatant activate signal transducers and activators of transcription (STATs) via VEGF receptor-2 (KDR) in human hemopoietic progenitor cells. Gynecol Oncol 2004; 94(1):125-133.

　　11.Zhang M, Lee AH, Binns CW, Xie X. Green tea consumption enhances survival of epithelial ovarian cancer. Int J Cancer 2004; 112(3):465-469.

　　12.Zhang M, Xie X, Lee AH, Binns CW. Sedentary behaviours and epithelial ovarian cancer. Cancer Cause Control 2004; 15:83-89.

　　13.Zhang M, Xie X, Lee AH, Binns CW. Soy and isoflavone intake are associated with reduced risk of ovarian cancer in Southeast China. Nutr Cancer 2004; 49(2):125-130.

　　14.Zhang M, Xie X, Lee AH, Binns CW. Prolonged lactation reduced ovarian cancer risk in Chinese women. Eur J Cancer Prev 2004; 13:499-502.

　　15.Chen HZ, Ye DF, Xie X, Lu W, Zhu C, Chen X. PTEN promoter methylation and protein expression in normal early placentas and hydatidiform moles. J Soc Gynecol Investig 2005;12:214-217.

　　16.Chen HZ, Ye DF, Xie X, Lu W, Zhu C, Chen X. Mismatch repair gene promoter methylation and expression in hydatidiform moles. Arch Gynecol Obstet 2005; 272(1):35-39.

　　17.Zhang M, Xie X, Lee AH, Binns CW, Holman CDJ. Body mass index in relation to ovarian cancer survival. Cancer Epidem Biomar 2005; 14(5):1307-1310.